Occudo Quantitative Strategies LP Sells 25,401 Shares of Genpact Limited (NYSE:G)

Occudo Quantitative Strategies LP lowered its stake in Genpact Limited (NYSE:G - Free Report) by 64.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 14,193 shares of the business services provider's stock after selling 25,401 shares during the period. Occudo Quantitative Strategies LP's holdings in Genpact were worth $610,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Mubadala Investment Co PJSC acquired a new stake in shares of Genpact during the 4th quarter worth $2,421,000. Millennium Management LLC lifted its position in Genpact by 829.4% during the fourth quarter. Millennium Management LLC now owns 1,057,389 shares of the business services provider's stock worth $45,415,000 after purchasing an additional 943,622 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Genpact by 12.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 216,126 shares of the business services provider's stock worth $9,282,000 after purchasing an additional 24,340 shares during the period. Lazard Asset Management LLC grew its stake in Genpact by 115.3% during the fourth quarter. Lazard Asset Management LLC now owns 80,319 shares of the business services provider's stock worth $3,448,000 after buying an additional 43,011 shares in the last quarter. Finally, Janus Henderson Group PLC bought a new position in Genpact in the 4th quarter valued at about $3,192,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Stock Up 0.3%

Shares of NYSE:G traded up $0.14 during mid-day trading on Tuesday, hitting $44.24. 174,278 shares of the company traded hands, compared to its average volume of 1,588,660. The stock has a 50-day moving average price of $47.92 and a two-hundred day moving average price of $47.30. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The stock has a market cap of $7.74 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.84 and a beta of 1.02. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The firm's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.73 EPS. On average, equities research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of Genpact stock in a transaction dated Tuesday, May 13th. The stock was bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on G. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Robert W. Baird cut their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Needham & Company LLC decreased their price target on Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, May 8th. Finally, Mizuho boosted their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $50.71.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.